Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
All of Us Research Program, |
RCV004807695 | SCV005431392 | uncertain significance | Hypercholesterolemia, autosomal dominant, 3 | 2024-05-30 | criteria provided, single submitter | clinical testing | This variant causes a G>A nucleotide substitution at the +1 position of intron 6 of the PCSK9 gene. Splice site prediction tools predict that this variant may have a significant impact on RNA splicing, which may result in the loss of PCSK9 function and have a protective effect against familial hypercholesterolemia. To our knowledge, RNA studies have not been reported for this variant. This variant has not been reported in individuals affected with PCSK9-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |